DRMA - Dermata Therapeutics, Inc.

QQQ $ 601.97 $ -1.85 (-0.31 %)

DIA $ 463.19 $ -1.45 (-0.31 %)

SPY $ 664.51 $ -2.35 (-0.35 %)

TLT $ 90.73 $ -0.23 (-0.25 %)

GLD $ 386.13 $ 0.17 (0.04 %)

Previous Close

$ 4.21

Open

$ 4.28

Bid

$ 4.18 x 130

Ask

$ 4.26 x 20

Day's Range

$ 4.12 - $ 4.14

52 Week Range

$ 3.83 - $ 23.70

Volume

50,179

Average Volume

Market Cap

2.87M

Beta (5Y Monthly)

$ -17.88

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2025	06-30-2025	10-Q
2	05-14-2025	03-31-2025	10-Q
3	03-17-2025	12-31-2024	10-K
4	11-13-2024	09-30-2024	10-Q
5	08-07-2024	06-30-2024	10-Q
6	05-15-2024	03-31-2024	10-Q
7	03-21-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-10-2023	06-30-2023	10-Q
10	05-11-2023	03-31-2023	10-Q
11	02-21-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-15-2022	06-30-2022	10-Q
14	05-16-2022	03-31-2022	10-Q
15	03-28-2022	12-31-2021	10-K
16	11-15-2021	09-30-2021	10-Q
17	09-27-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Tuesday's ...
10/07/2025 17:06:17

12 Health Care Stocks Moving In Tuesday's ...
10/07/2025 12:08:21

why-telomir-pharmaceuticals-shares-are-trading-higher-by-31-here-are-20-stocks-moving-premarket

Why Telomir Pharmaceuticals Shares Are Tra...
10/07/2025 09:28:45

12 Health Care Stocks Moving In Monday's A...
10/06/2025 21:06:27

Dermata Therapeutics Announces Australian ...
10/02/2025 12:02:09

- This acceptance follow's Dermata's U.S. issued patent covering its Spongilla technology combination as a method to to...

Dermata Therapeutics To Present Phase 3 ST...
09/17/2025 06:14:53

- Abstract highlights additional primary and secondary data from Phase 3 STAR-1 clinical study of XYNGARI™ for the treatment of...

Dermata Therapeutics Announces Strategic P...
09/10/2025 12:09:19

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a science-driven leader in...

12 Health Care Stocks Moving In Wednesday'...
09/03/2025 21:06:23

Maxim Group Maintains Buy on Dermata Thera...
08/21/2025 16:32:02

Maxim Group analyst Anthony Vendetti maintains Dermata Therapeutics (NASDAQ:DRMA) with a Buy and lowers the price target fro...

Dermata Therapeutics Q2 EPS $(1.66) Beats ...
08/13/2025 21:09:21

Dermata Therapeutics To Effect 1-for-10 Re...
08/01/2025 09:30:11

Trading Halt: Halted at 7:50:00 p.m. ET - ...
07/31/2025 23:50:04

Australian Patent Office Dermata Therapeut...
07/08/2025 12:11:43

- This is the Company's second granted patent for DMT410, using its Spongilla technology to topically deliver botulinum tox...

12 Health Care Stocks Moving In Monday's A...
07/07/2025 21:06:29

Maxim Group Maintains Buy on Dermata Thera...
05/21/2025 14:51:59

Maxim Group analyst Anthony Vendetti maintains Dermata Therapeutics (NASDAQ:DRMA) with a Buy and lowers the price target fro...

Dermata Therapeutics Initiates Manufacturi...
05/21/2025 13:04:14

Dermata's XYNGARI Phase 3 Trial Hits Stati...
04/15/2025 12:42:06

- Dermata previously announced XYNGARI(TM) produced highly statistically significant topline data for all primary endpoints at ...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
03/28/2025 12:05:48

us-stocks-likely-to-open-lower-analysts-warn-prolonged-uncertainty-could-hurt-both-us-and-global-risk-assets

US Stocks Likely To Open Lower, Analysts W...
03/28/2025 09:31:22

U.S. stock futures fell on Friday after two consecutive days of decline on Wednesday and Thursday. Futures of benchmark indices...

gold-gains-over-1-td-synnex-shares-plunge-after-downbeat-results

Gold Gains Over 1%; TD SYNNEX Shares Plung...
03/27/2025 16:12:53